SCHEMBL17739701

SCHEMBL17739701

C=C(C)[C@@H]1Cc2cc(C(C)=O)c(O)cc2O1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ HPGD P15428 4/20 0.53
▸ KDM4E B2RXH2 4/20 0.53
▸ LMNA P02545 2/20 0.53
▸ GAA P10253 2/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ MAPK1 P28482 1/20 0.47
▸ POLB P06746 1/20 0.45
▸ APEX1 P27695 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ CYP3A4 P08684 3/20 0.38
▸ MAPT P10636 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ HTT P42858 3/20 0.36
▸ MPI P34949 1/20 0.35
▸ APOBEC3G Q9HC16 1/20 0.35
▸ ALOX5 P09917 1/20 0.34
▸ CA9 Q16790 1/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17728865 1.00 ALDH1A1 (0.53) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL17739703 0.83 KDM4E (0.48) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL31237477 0.82 ALDH1A1 (0.50) ALDH1A1HPGDKDM4ELMNAGAA
Viscidone SCHEMBL6266796 0.81 POLB (0.63) ALDH1A1HPGDKDM4ELMNAGAA
Viscidone SCHEMBL29388492 0.81 POLB (0.63) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL10636325 0.75 LTB4R (0.51) ALDH1A1HPGDCYP3A4TDP1
Tremetone SCHEMBL4743839 0.75 POLB (0.75) ALDH1A1HPGDKDM4ELMNAGAA
Tremetone SCHEMBL4743840 0.75 POLB (0.75) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL9764777 0.72 NFKB1 (0.46) ALDH1A1HPGDMAPK1CYP3A4TDP1
SCHEMBL30991577 0.70 CYP4F2 (0.59) ALDH1A1HPGDPOLBCYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663453-B2 Metabolites and oximes with vasodilator and hypotensive activity UNIVERSIDAD DE ANTOFAGASTA (CL) 2017-05-30 — — US disclosed
US-9663453-B2 Metabolites and oximes with vasodilator and hypotensive activity UNIVERSIDAD DE ANTOFAGASTA (CL) 2017-05-30 — — US disclosed
US-20160130219-A1 METABOLITES AND OXIMES WITH VASODILATOR AND HYPOTENSIVE ACTIVITY UNIVERSIDAD DE ANTOFAGASTA (CL) 2016-05-12 — — US disclosed
US-20160130219-A1 METABOLITES AND OXIMES WITH VASODILATOR AND HYPOTENSIVE ACTIVITY UNIVERSIDAD DE ANTOFAGASTA (CL) 2016-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130219-A1 METABOLITES AND OXIMES WITH VASODILATOR AND HYPOTENSIVE ACTIVITY PTGIS, ACHE, VASP ALDH1A1 4052/4885HPGD 147/4885KDM4E 1261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback